Clinical implications for the administration of colony stimulating factors.

Journal Article (Journal Article)

This article familiarizes the practitioner with the clinical nursing implications of the colony stimulating factors that have been approved for use. The process of hematopoiesis is reviewed with a focus on the mechanisms of action for Sargramostim, Filgrastim, and Epoetin Alfa. Each agent is discussed individually and information is presented regarding indications, pharmacologic properties, routes of administration, and potential adverse reactions. Nursing interventions for care of the patient receiving colony stimulating factors are discussed.

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Schneider, Susan Moeller

Cited Authors

Schneider, SM

Published Date

January 1994

Published In

Orthopedic Nursing

Volume / Issue

13 / 1

Start / End Page

56 - 64

PubMed ID

8164990

Electronic International Standard Serial Number (EISSN)

1542-538X

International Standard Serial Number (ISSN)

0744-6020

Digital Object Identifier (DOI)

10.1097/00006416-199401000-00011

Scholars@Duke